RT
Ratio Therapeutics, Inc.
SEC filingPharmaceuticals · Boston, MA
Amount raised$70Msold at filing
Total offering$70M
Investors in the raise57count reported to the SEC
FiledJul 31, 2026first sale Jul 16, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Scott W. MacDonaldExecutive Officer
Marc W. BeckerExecutive Officer
Albert W. HolmanDirector
Brandon W. IngersollDirector
Allan W. GreenDirector
William W. CowanDirector
John W. HoppinExecutive Officer, Director
John W. BabichDirector
Susan W. WhoriskeyDirector
Executive officers, directors and promoters as listed on the Form D.